Financials
- Market Capitalization 39.32 B
- Employee 883
- Founded 2014
- CEO N/A
- Website www.revmed.com
- Headquarter Delaware, United States
- FIGI BBG00829F4P8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-13.39
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 240 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 656.11 USD | -1.05% | -2.98% | +6.97% | +14.59% | 68.79 B USD | ||
| 295 | ARGX argenx SE - American Depositary Shares | 859.14 USD | -1.95% | -6.61% | -3.76% | +51.52% | 53.17 B USD | ||
| 387 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 281.31 USD | -2.34% | -12.53% | -0.57% | -11.23% | 37.56 B USD | ||
| 492 | MRNA Moderna, Inc. - Common Stock | 67.45 USD | +0.66% | -15.44% | +31.28% | +103.22% | 26.76 B USD |